1. What Is the Nuclear Medicine Imaging Market?
The Nuclear Medicine Imaging Market covers SPECT, PET, and hybrid PET-CT and PET-MRI systems using radiotracer-labeled pharmaceuticals to image metabolic and molecular processes for oncology staging, cardiac perfusion, neurological assessment, and theranostic applications. Nuclear medicine physicians, nuclear cardiologists, and oncologists deploy gamma cameras, SPECT systems, and PET scanners to assess cancer metabolism, cardiac viability, Alzheimer's disease amyloid burden, and infection imaging. The market includes SPECT systems, time-of-flight PET scanners, digital PET systems, and hybrid PET-CT platforms.
2. Nuclear Medicine Imaging Market Size & Forecast
3. Emerging Technologies
- Long axial field of view PET scanners enabling total-body pharmacokinetic imaging with unprecedented sensitivity for low-dose and rapid imaging.
- AI-powered SPECT reconstruction improving image quality and reducing acquisition time for cardiac perfusion and skeletal imaging.
- Digital SPECT cadmium zinc telluride detector technology providing improved sensitivity and energy resolution versus traditional sodium iodide detectors.
- Theranostic dosimetry imaging platforms integrating SPECT or PET imaging with radiopharmaceutical therapy dose optimization.
Similar technologies are also transforming adjacent markets. Learn more in our Ct Scanner Market.
4. Key Market Opportunity
PSMA PET scanner demand is driving prostate cancer center nuclear medicine investment. Theranostic nuclear medicine program expansion combining diagnostic and therapeutic radiopharmaceuticals is the fastest-growing clinical application. Emerging market nuclear medicine infrastructure development represents the largest volume growth opportunity as PET access expands globally.
5. Top Companies in the Nuclear Medicine Imaging Market
The following organisations hold leading positions in the Nuclear Medicine Imaging Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- Mediso
- Spectrum Dynamics
- Positron
- pSemi
- MiE Medical Research
6. Market Segmentation
The Nuclear Medicine Imaging Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By System Type | SPECT Gamma Camera SPECT-CT Hybrid PET Scanner PET-CT Hybrid PET-MRI Hybrid |
| By Application | Oncology PET-CT Staging Cardiac SPECT Perfusion Neurological PET Imaging Infection and Inflammation Imaging Theranostic Dosimetry |
| By Radiotracer | FDG PET PSMA PET Amyloid PET Cardiac Perfusion SPECT DOTATATE PET |
| By End-User | Nuclear Medicine Departments PET Centers Academic Medical Centers Radiopharmacy Networks |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Nuclear Medicine Imaging Market trajectory over the forecast period:
PSMA PET imaging is transforming prostate cancer management as gallium-68 PSMA and fluorine-18 PSMA PET accurately detect recurrent and metastatic prostate cancer at lower PSA levels than conventional imaging.The PSMA PET superiority over bone scan and CT for prostate cancer staging is driving systematic adoption at cancer centers. The PSMA theranostic pairing with PSMA-targeted radiopharmaceutical therapy is creating integrated diagnostic and therapeutic nuclear medicine programs.
Digital PET systems are improving scanner sensitivity and image quality through silicon photomultiplier detector technology.Digital PET scanners including GE HealthCare Discovery MI and Siemens Biograph Vision Quadra achieve substantially improved sensitivity enabling lower radiotracer doses, shorter scan times, and improved lesion detectability. The digital PET sensitivity advantage is creating premium system demand at academic centers and high-volume PET facilities.
Total-body PET scanners covering the complete body in a single acquisition are enabling new pharmacokinetic imaging applications and substantially reducing scan times and radiotracer doses.UEXPLORER and other total-body PET systems enabling simultaneous whole-body imaging are opening new research and clinical applications. The total-body PET capability is driving academic and research institution procurement of next-generation PET infrastructure.
For related market intelligence, see the Mri Systems Market.
8. Segmental Analysis
By system type, the PET-CT hybrid segment dominated the Nuclear Medicine Imaging Market in 2025, as PET-CT representing the standard oncology staging and restaging platform sustains the largest nuclear medicine system revenue across cancer centers and academic medical institutions globally.
By application, the PSMA PET prostate cancer imaging segment is projected to register the highest growth rate through 2034, as PSMA PET superiority in prostate cancer staging and its theranostic pairing with PSMA radiopharmaceutical therapy is driving systematic center adoption globally.
9. Regional Analysis
Regional demand patterns across the Nuclear Medicine Imaging Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Nuclear Medicine Imaging Market in 2025, accounting for around 42 percent of global revenue. The United States nuclear medicine department infrastructure combined with expanding PSMA PET and amyloid PET clinical adoption drives substantial system procurement. Siemens Healthineers, GE HealthCare, and Philips Healthcare generate dominant U.S. nuclear medicine imaging revenue. Moreover, U.S. academic medical centers drive total-body PET and digital PET adoption at the technology frontier.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR in the Nuclear Medicine Imaging Market through 2034. The region's expanding cancer treatment infrastructure combined with growing nuclear medicine access is driving substantial PET and SPECT system procurement. Chinese nuclear medicine expansion through growing PET center development and domestic manufacturing at United Imaging Healthcare creates substantial regional demand. Japanese and Korean nuclear medicine infrastructure supports systematic adoption of digital PET and PSMA imaging.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Nuclear Medicine Imaging Market was valued at USD 4.85 Bn in 2025 and is projected to reach USD 10.88 Bn by 2034, growing at a CAGR of 9.4% over the 2026–2034 forecast period.
The Nuclear Medicine Imaging Market is projected to grow at a CAGR of 9.4% from 2026 to 2034.
North America dominated the Nuclear Medicine Imaging Market in 2025, accounting for around 42 percent of global revenue.
The leading companies in the Nuclear Medicine Imaging Market include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, United Imaging Healthcare, Mediso, Spectrum Dynamics, Positron, pSemi, MiE Medical Research.
Psma pet imaging is transforming prostate cancer management as gallium-68 psma and fluorine-18 psma pet accurately detect recurrent and metastatic prostate cancer at lower psa levels than conventional imaging.
By system type, the PET-CT hybrid segment dominated the Nuclear Medicine Imaging Market in 2025, as PET-CT representing the standard oncology staging and restaging platform sustains the largest nuclear medicine system revenue across cancer centers and academic medical institutions globally.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 4 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 4 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 4 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.